Suchergebnisse - "Paats, Marthe S"

PubPharm (44)

1

Hepatotoxicity in patients with non-small cell lung cancer treated with sotorasib after prior immunotherapy : a comprehensive clinical and pharmacokinetic analysis

enthalten in: EBioMedicine | 2024

von Ernst, S. | Hofman, M. | van der Horst, T. | +11

2

Clinical utility of circulating tumor DNA in patients with advanced KRASG12C-mutated non-small cell lung cancer treated with sotorasib

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2024

von Ernst, S. | van Marion, R. | Atmodimedjo, P. | +10

3

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion-positive non-small cell lung cancer

enthalten in: Cancer | 2024

von van Veggel, B. | van der Wekken, A. | Paats, M. | +8

4

A phase 2 trial combining afatinib with cetuximab in patients with EGFR exon 20 insertion–positive non–small cell lung cancer

enthalten in: Cancer | 2024

von Veggel, B. | Wekken, A. | Paats, M. | +8

5

Exploring the impact of patient-specific clinical features on osimertinib effectiveness in a real-world cohort of patients with EGFR mutated non-small cell lung cancer

enthalten in: International journal of cancer | 2024

von van Veelen, A. | Veerman, G. | Verschueren, M. | +15

6

Efficacy and Tolerability of Osimertinib and Sotorasib Combination Treatment for Osimertinib Resistance Caused by KRAS G12C Mutation : A Report of Two Cases

enthalten in: JCO precision oncology | 2023

von Ernst, S. | Uzun, S. | Paats, M. | +8

7

Analysis of Serious Weight Gain in Patients Using Alectinib for ALK-Positive Lung Cancer

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von de Leeuw, S. | Pruis, M. | Sikkema, B. | +9

CommentIn: J Thorac Oncol. 2023 Aug;18(8):967-969. - PMID 37479325

8

Chemotherapy for patients with EGFR-mutated NSCLC after progression on EGFR-TKI's : Exploration of efficacy of unselected treatment in a multicenter cohort study

enthalten in: Lung cancer (Amsterdam, Netherlands) | 2023

von Steendam, C. | Ernst, S. | Badrising, S. | +4

9

Influence of Food With Different Fat Concentrations on Alectinib Exposure : A Randomized Crossover Pharmacokinetic Trial

enthalten in: Journal of the National Comprehensive Cancer Network : JNCCN | 2023

von Lanser, D. | de Leeuw, S. | Oomen-de Hoop, E. | +7

CommentIn: J Natl Compr Canc Netw. 2023 Oct;21(10):xxiii.a-xxiv.a. - PMID 37879366

10

Cardiac Toxicity of Alectinib in Patients With ALK+ Lung Cancer : Outcomes of Cardio-Oncology Follow-Up

enthalten in: JACC. CardioOncology | 2023

von Pruis, M. | Veerman, G. | Hassing, H. | +6

1
2
3
4
5
Nächster »
[5]